Company Performance Metrics
- Marie Le Grand: FounderPast Role: PhysioStim, Founder, Chief Executive Officer, and President
PhysioStim specializes in preclinical cardiovascular pharmacology and electrophysiology, offering a comprehensive range of studies including hERG-GLP, cardiac ion channel assays, and Langendorff preparations. With a focus on cardiovascular safety of new drugs or compounds, PhysioStim provides essential assays such as hERG and hNaV1.5 peak. The
company also conducts cardiac telemetry assays for preclinical drug studies, utilizing radio transmitter equipped animals for non-invasive measurements. Additionally, PhysioStim offers the PhysioStim device, a non-invasive treatment option for difficult-to-heal fractures, boasting a high clinical success rate. With over two decades of experience, PhysioStim is recognized for its expertise in cardiovascular and vascular functions.
